technetium-tc-99m-medronate has been researched along with Fibromatosis--Abdominal* in 2 studies
2 other study(ies) available for technetium-tc-99m-medronate and Fibromatosis--Abdominal
| Article | Year |
|---|---|
Diffuse abdominal uptake of technetium-99m-HDP after colectomy in Gardner's syndrome.
A 37-yr-old man presented with increasing abdominal girth and multiple palpable intra-abdominal masses 3 yr after colectomy for polyposis coli. Whole-body skeletal scintigraphy performed prior to laparotomy demonstrated diffuse abdominal uptake of 99mTc-HDP consistent with mesenteric fibromatosis confirmed at surgery. When diffuse abdominal uptake of skeletal imaging agents occurs in patients with prior colectomy for polyposis coli, mesenteric fibromatosis as a manifestation of Gardner's syndrome should be suspected. This case illustrates another cause of diffuse abdominal uptake of skeletal imaging agents. Topics: Abdomen; Adult; Bone Neoplasms; Colectomy; Colonic Polyps; Fibromatosis, Abdominal; Gardner Syndrome; Humans; Male; Radionuclide Imaging; Technetium Tc 99m Medronate | 1995 |
Triple-phase bone scan findings in aggressive fibromatosis. Before and after radiation therapy.
The authors present comparative triple-phase bone scan findings in three cases of histologically proven aggressive fibromatosis both before (initial evaluation) and after radiation therapy. The purpose of the study was to compare triple-phase bone scan findings in aggressive fibromatosis both before and after radiation therapy and to determine whether any additional physiological information could be obtained. Before radiation therapy, the triple-phase bone scintigraphy demonstrated increased flow and radiotracer pooling in the areas of tumors on dynamic flow and immediate blood pool images, respectively. However, the delayed static images demonstrated variable radiotracer uptake. When compared to preradiation therapy triple-phase bone scan, decreased vascularity was well demonstrated in all three patients after radiation therapy. In addition, it also provided information regarding the changes in the size and extent of tumor, noninvaded underlying bone, and remainder of the skeleton. This additional information can be particularly useful in patients with equivocal or questionable histologic diagnosis especially from small, unrepresentative biopsies. Topics: Adult; Biopsy; Bone and Bones; Bone Neoplasms; Female; Fibromatosis, Abdominal; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Radiotherapy Dosage; Technetium Tc 99m Medronate; Time Factors | 1994 |